0001757898 2026-05-07 2026-05-07 0001757898 ste:STETwo700SeniorNotesDue2031MemberMember 2026-05-07 2026-05-07 0001757898 ste:Two700SeniorNotesDue2051MemberMember 2026-05-07 2026-05-07 0001757898 us-gaap:CommonStockMember 2026-05-07 2026-05-07 0001757898 8-K/A true 2026-05-07 STERIS plc L2 001-38848 98-1455064 70 Sir John Rogerson’s Quay Dublin 2 IE D02 R296 353 1 232 2000 false false false false Ordinary Shares, $0.001 par value STE NYSE 2.700% Senior Notes due 2031 STE/31 NYSE 3.750% Senior Notes due 2051 STE/51 NYSE false On May 7, 2026, STERIS plc (the “Company”) filed a Current Report on Form 8-K (the “Original Form 8-K”), which included disclosure under Item 5.02. The Original Form 8-K reported that the Board of Directors of the Company (the “Board”) increased its size from nine to ten members on May 5, 2026, and elected Pierre Boulud to serve as a Director effective as of that date. In accordance with the Instructions to Item 5.02 of Form 8-K, this Current Report on Form 8-K/A reports Mr. Boulud’s initial Board committee assignments. No other changes have been made to the Original Form 8-K.